Genoox and Microsoft Healthcare partner to help advance precision medicine
Genoox announced today it is partnering with Microsoft Healthcare to bring its Microsoft Genomics service to Genoox’s global customers to help advance precision medicine. Genoox specializes in translating complex genetic data into clear, timely, and actionable clinical answers via purpose-built genetic applications.
Combining the performance and scalability of Microsoft’ Genomics’ world-class Azure cloud with Genoox’s comprehensive cloud-based advanced framework for Next-Generation DNA Sequencing (NGS) will advance the fields of genomics, healthcare and Artificial Intelligence (AI) and benefit clinicians and scientists who require rapid delivery of clinically actionable insights and disease diagnoses.
Genoox is a healthcare technology company that has sought to remove the final barrier to widespread adoption of clinical NGS, enabling personalized medicine for mainstream patients. Genoox provides a comprehensive SaaS platform allowing organizations to develop customized, NGS-based, clinical genetic applications comprising that are powered by advanced AI and machine-learning (ML) algorithms, to be used in the diagnosis and treatment of reproductive health, inherited disorders and Oncology. By facilitating rapid and precise genomic analysis, interpretation and reporting, Genoox provides a uniquely comprehensive solution to improve clinical outcomes.
Microsoft Healthcare and Genoox have integrated Microsoft Genomics NGS pipeline into Genoox’s comprehensive platform. Together, the two companies intend to offer the Microsoft Genomics service for secondary genomic analysis to selected Microsoft Enterprise users, including clinicians and researchers seeking to run clinical applications.
Using the Microsoft Genomics pipeline on the Genoox platform, Microsoft Enterprise users will have full ability to query millions of data sources in near real time, yielding rapid translation of complex genetic data into specific, actionable insights that can be shared with the patient and, ultimately, swift diagnosis and enhanced patient care.
“Microsoft is a trusted partner for enterprises, and we are thrilled to integrate Microsoft’s pipeline into Genoox’s platform. We believe that with mutual efforts, both organizations will increase Microsoft’s ability to offer their customers with clinical testing development capabilities, improve patient outcomes and reduce the time to market for clinical applications.” said CEO Amir Trabelsi, who cofounded Genoox in 2014.
Trent Norris, Senior Program Manager at Microsoft Healthcare added, “The collaboration with Genoox broadens our healthcare partner portfolio and brings us closer to actionable insights at the patient-provider level while addressing the heavy manual requirements of transforming disparate datatypes. This proposition is in line with our goal of providing AI and machine learning processing services for healthcare to handle a diverse set of data-rich workloads.”